×
For best experience we recommend to activate Javascript in your browser.
MAPK7 antibody (C-Term) (Biotin)
This Rabbit Polyclonal antibody specifically detects MAPK7 in WB, IHC and ELISA. It exhibits reactivity toward Human.
Quick Overview for MAPK7 antibody (C-Term) (Biotin) (ABIN2261974)
Target
See all MAPK7 Antibodies
MAPK7
(Mitogen-Activated Protein Kinase 7 (MAPK7))
Reactivity
All reactivities for MAPK7 antibodies
Human
Host
All hosts for MAPK7 antibodies
Rabbit
Clonality
All clonalities for MAPK7 antibodies
Polyclonal
Conjugate
All conjugates for MAPK7 antibodies
This MAPK7 antibody is conjugated to Biotin
Application
All applications for MAPK7 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-MAPK7 Antibody (Biotin)
(hide)
Binding Specificity
All epitopes for MAPK7 antibodies
AA 776-805, C-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
ERK5, CT (Extracellular Signal-regulated Kinase 5, ERK-5, Big MAP Kinase 1, BMK1, BMK-1, Mitogen-activated Protein Kinase 7, MAP Kinase 7, MAPK 7, MAPK7, PRKM7) (Biotin)
Purification
Purified by ammonium sulfate precipitation.
Immunogen
KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 776-805 in the C-terminal region of human ERK5, UniProt # Q13164. Species Sequence Homology: mouse, rat, bovine
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2.
Storage
-20 °C
Storage Comment
-20°C
Target Details for MAPK7
(hide)
Target
MAPK7
(Mitogen-Activated Protein Kinase 7 (MAPK7))
Alternative Name
ERK5
UniProt
Q13164
Pathways
MAPK Signaling , Neurotrophin Signaling Pathway , Activation of Innate immune Response , cAMP Metabolic Process , Toll-Like Receptors Cascades , Negative Regulation of intrinsic apoptotic Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat